Chartwell Molecular Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL MOLECULAR, and what generic and branded alternatives to CHARTWELL MOLECULAR drugs are available?
CHARTWELL MOLECULAR has eighty-eight approved drugs.
There are two tentative approvals on CHARTWELL MOLECULAR drugs.
Drugs and US Patents for Chartwell Molecular
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Molecular | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | SOLUTION;ORAL | 073680-001 | Oct 27, 1992 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Molecular | LAMOTRIGINE | lamotrigine | TABLET;ORAL | 077783-003 | Nov 1, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Molecular | ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 204552-001 | Mar 20, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Chartwell Molecular | LIDOCAINE HYDROCHLORIDE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 040708-001 | Feb 27, 2007 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chartwell Molecular
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chartwell Molecular | MYKROX | metolazone | TABLET;ORAL | 019532-001 | Oct 30, 1987 | 4,517,179 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.